Posted on September 2nd, 2007 at 11:06 am by Editor
Two executives with the Arizona Diamondbacks have purchased majority interest in the NASCAR team owned by Troy Aikman and Roger Staubach, The Associated Press learned Saturday night. Jeff Moorad, chief executive officer of the Diamondbacks, and Tom Garfinkel, the chief operating officer, will be introduced as the controlling owners of Hall of Fame Racing at a Sunday news conference at California Speedway, two people familiar with the deal told the AP. They requested anonymity because the formal announcement had yet to be made. Aikman and Staubach, Hall of Fame quarterbacks for the Dallas Cowboys, formed their race team with three other partners in 2003. The No. 96 is in its second full season, driven by Tony Raines and sponsored by Texas-based DLP HDTV.
The original ownership group, including Aikman and Staubach, will remain involved as minority owners. But Moorad, who is part of the Diamondbacks ownership group, and Garfinkel will have controlling interest. Garfinkel has vast racing experience through his previous role as executive vice president of Chip Ganassi Racing. He spent five years working directly under Ganassi and was intimately involved in every aspect of Ganassi’s NASCAR and open-wheel organizations. Moorad founded his own management company in 1983, and has represented athletes such as Manny Ramirez, Will Clark, Steve Young, Warren Moon, and Aikman. It was that previous relationship with Aikman that led the executives to Hall of Fame Racing when they began looking for a team to purchase.
Hall of Fame Racing has a close alliance with Joe Gibbs Racing, and that’s not expected to change with the sale. Gibbs currently fields Chevrolets, but is expected to announce next week that it is switching to Toyota. Although aspects of the Hall of Fame sale are still being discussed, sources told The AP the team will use the same manufacturer that Gibbs does next season.
No Comments » No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
Please keep your comments relevant to this blog entry: inappropriate or purely promotional comments may be removed.
